Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - Enters transfer of business deal and a premix and market-ready solutions supply deal for its product Fruitflow. Both will take effect from January 1, 2023. Says the agreements should lead to a substantial increase annual sales and net profit.
Expects to report revenue of GBP426,000 for the year ended March 31 and an underlying operating loss of GBP173,000. Revenue for financial 2021 amounted to GBP211,195.
Files new patent application related to the use of Fruitflow to confer health benefits in modulating the gut microbiome of humans.
Fruitflow is a supplement that supports healthy blood flow and heart health, Provexis explains.
Current stock price: 0.98 pence, up 13% on Wednesday
12-month change: down 17%
By Abby Amoakuh; abbyamoakuh@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Provexis (PXS)